Expression of 17 beta-hydroxysteroid dehydrogenase type 2 in pelvic endometriosis
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Lack of expression or a deficiency of 17beta-hydroxysteroid dehydrogenase type 2 (17beta-HSD2), a key enzyme in estradiol inactivation, could be involved in the pathophysiology of endometriosis. The aim of the present study was to evaluate expression of the gene (17beta-Hsd2) encoding 17beta-HSD2 in eutopic and ectopic endometrial tissues of women with endometriosis. Thirty-four infertile women were divided into a control group, without any clinical or laparoscopic evidence of endometriosis (n = 19), and a group with pelvic endometriosis (n = 15). Diagnosis was confirmed by histological examination of the endometriotic lesions. 17beta-Hsd2 mRNA expression was detected by reverse transcription-polymerase chain reaction in the control group (54% of the samples), in the eutopic endometrium of patients with endometriosis (83% of the specimens analyzed) and in all endometriotic lesions. The semi-quantitative analysis of 17beta-Hsd2 mRNA showed a significantly higher gene expression in the endometriotic implants compared with the intrauterine endometrium of the control group (p < 0.05). 17beta-HSD2 protein was localized to the glandular epithelium of both eutopic endometrium and endometriotic implants. The present results refute the hypothesis of lower or absent 17beta-HSD2 expression in pelvic endometriosis; therefore further studies are needed to assess other potential mechanisms leading to increased estrogenic activity within endometriotic implants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aromatase expression in endometriosis.
Noble, L. S., Simpson, E. R., Johns, A., & Bulun, S. E. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.1.8550748 · Cited by 566 · cited 2×
“Endometriotic tissue expresses aromatase aberrantly [10], which could be viewed as an adjunctive factor for implant survival, but surely other mechanisms must be involved to allow endometriosis development.”
Zeitoun, K., Takayama, K., Sasano, H., Suzuki, T., Moghrabi, N., Andersson, S., Johns, A., Meng, L., Putman, M., Carr, B., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.12.5301 · Cited by 308
Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target
Zeitoun, K. M., & Bulun, S. E. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00393-3 · Cited by 256 · cited 1×
“As endometriosis is an estrogen-dependent disease, a number of abnormalities related to steroid action or production could be linked to its pathophysiology [10–12].”
Casey, M. L., MacDonald, P. C., & Andersson, S. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117569 · Cited by 212
Endometriosis: The Ultimate Hormonal Disease
(2003) · Seminars in Reproductive Medicine · doi:10.1055/s-2003-41319 · Cited by 94 · cited 1×
“As endometriosis is an estrogen-dependent disease, a number of abnormalities related to steroid action or production could be linked to its pathophysiology [10–12].”
Mustonen, M. V. J., Isomaa, V. V., Vaskivuo, T., Tapanainen, J., Poutanen, M. H., Stenbäck, F., Vihko, R. K., & Vihko, P. T. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.4.4709 · Cited by 84
Research works printed but not linked: 14
- Sampson J A, 1927, Am J Obstet Gynecol, 14, 422, 10.1016/S0002-9378(15)30003-X · DOI · Paper page
- Lebovic D I, 2001, Fertil Steril, 75, 1, 10.1016/S0015-0282(00)01630-7 · DOI · Paper page
- Gazvani R, 2002, Int J Gynecol Obstet, 76, 117, 10.1016/S0020-7292(01)00577-X · DOI · Paper page
- Metzger D, 1992, Infertil Reprod Clin N Am, 3, 597
- Sharpe-Timms K L, 2002, Ann N Y Acad Sci, 955, 313
- Andersson S, 1997, Steroids, 62, 143, 10.1016/S0039-128X(96)00173-0 · DOI
- Adamski J, 2001, Moll Cell Endocrinol, 171, 1, 10.1016/S0303-7207(00)00383-X · DOI · Paper page
- Mustonen V JM, 1998, J Clin Endocrinol Metab, 83, 1319
- Noble L S, 1996, J Clin Endocrinol Metab, 81, 174
- American Society of Reproductive Medicine, 1997, Fert Steril, 67, 817, 10.1016/S0015-0282(97)81391-X · DOI · Paper page
- Noyes R W, 1950, Fertil Steril, 1, 3, 10.1016/S0015-0282(16)30062-0 · DOI · Paper page
- Gussow D, 1987, J Immunol, 139, 3132, 10.4049/jimmunol.139.9.3132 · DOI · Paper page
- Zeitoun K, 1998, J Clin Endocrinol Metab, 83, 4474
- Matsuzaki S, 2005, Fertil Steril, 85, 308, 10.1016/j.fertnstert.2005.08.017 · DOI
Cited by
Endometrial alterations in endometriosis: a systematic review of putative biomarkers
May, K. E., Villar, J., Kirtley, S., Kennedy, S. H., & Becker, C. M. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmr013 · Cited by 237
Estrogen metabolism and action in endometriosis
Rižner, T. L. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.03.022 · Cited by 153
Estrogen biosynthesis and signaling in endometriosis
Huhtinen, K., Ståhle, M., Perheentupa, A., & Poutanen, M. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.08.022 · Cited by 107
Hevir, N., Vouk, K., Šinkovec, J., Ribič-Pucelj, M., & Lanišnik Rižner, T. (2011) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2011.01.003 · Cited by 48
Nie, J., Yi, Y., Liu, X., & Guo, S.-W. (2025) · Human Reproduction Open · doi:10.1093/hropen/hoaf028 · Cited by 11
Metadata
- Authors
- Carneiro, M. M., Morsch, D. M., Camargos, A. F., Spritzer, P. M., & Reis, F. M.
- Venue
- Gynecological Endocrinology
- Publisher
- Informa UK Limited
- Published
- 2007-01
- Volume
- 23
- Issue
- 4
- Pages
- 188-192
- ISSN
- 0951-3590 (ISSN-L)
- 1473-0766
- OpenAlex
- W2169417859
- Cited by
- 14
- References
- 6
- FWCI
- 1.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Expression of 17 beta-hydroxysteroid dehydrogenase type 2 in pelvic endometriosis. https://app.cochat.ai/papers/10.1080/09513590701200850
- The paper
- Carneiro, M. M., Morsch, D. M., Camargos, A. F., Spritzer, P. M., & Reis, F. M. (2007). Expression of 17 beta-hydroxysteroid dehydrogenase type 2 in pelvic endometriosis. Gynecological Endocrinology. https://doi.org/10.1080/09513590701200850
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.